2017
DOI: 10.1016/j.ejogrb.2016.12.020
|View full text |Cite
|
Sign up to set email alerts
|

Human papillomavirus (HPV) persistence and HPV 31 predict the risk of recurrence in high-grade vaginal intraepithelial neoplasia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
35
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
5

Relationship

3
2

Authors

Journals

citations
Cited by 31 publications
(37 citation statements)
references
References 13 publications
2
35
0
Order By: Relevance
“…HPV testing was performed using the Clinical Array Technology HPV 2 assay (CLART; Genomica, Madrid, Spain), which combines highly specific and sensitive PCR with low‐density array technology. Details regarding HPV testing have been reported elsewhere …”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…HPV testing was performed using the Clinical Array Technology HPV 2 assay (CLART; Genomica, Madrid, Spain), which combines highly specific and sensitive PCR with low‐density array technology. Details regarding HPV testing have been reported elsewhere …”
Section: Methodsmentioning
confidence: 99%
“…Growing evidence supports the safety profile of the new vaccine . Ideally, the widespread implementation of the 9vHPV‐V will dramatically reduce the prevalence of HPV‐related conditions …”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…HPV testing was performed using a previously reported method . Demographic details, HPV data, and data related to the treatment of precancerous and cancerous lesions were reviewed retrospectively; data were retrieved from a dedicated database at the study institution that was updated prospectively at regular intervals.…”
Section: Methodsmentioning
confidence: 99%
“…Treatments included: topical application of imiquimod or 5‐fluorouracil (5‐FU), as well as ablative and excisional procedures executed via conventional surgery, electrosurgery and carbon dioxide LASER . The risk of developing invasive vaginal cancer in those patients remains unclear, ranging between 2% and 12% in different series . Recently, a multi‐institutional Italian study reports that more than 10% of women initially diagnosed with high‐grade vaginal intraepithelial neoplasia are detected with occult invasive vaginal cancer at the time of excisional procedure, thus suggesting the need to achieve a histological diagnosis before proceeding to ablative or medical treatments .…”
Section: Introductionmentioning
confidence: 99%